KoreaTimes - Bio

The Korea Times

The Korea Times

The Korea Times

Business

Bio

Thu, November 30, 2023 | 00:27

'SK Bioscience's vaccine effective against Omicron variant'

'SK Bioscience's vaccine effective against Omicron variant'

SK Bioscience's SKYCovione coronavirus vaccine was proven to be effective against the Omicron variant. The company said Wednesday that it confirmed the effective immune response when people received a booster shot of the vaccine. SKYCovione, also known as GBP510, is Korea's first COVID-19 vaccine. SK Bioscience obtained approval for the use of the recombinant protein-based va...

Baek Byung-yeul | 2022-07-13 16:05

HanAll Biopharma set to expand presence in Asia with autoimmune treatment

HanAll Biopharma set to expand presence in Asia with autoimmune treatment

Local biotech company HanAll Biopharma is seeking to expand its presence in Asia, as the company is set to begin Phase 3 clinical testing of its autoimmune disease treatment candidate in Japan in the second half of 2022, the company said Monday.

Baek Byung-yeul | 2022-07-11 16:58

SD Biosensor to acquire US diagnostic firm Meridian for $1.53 bil.

SD Biosensor to acquire US diagnostic firm Meridian for $1.53 bil.

SD Biosensor, a local biotech company known for its COVID-19 test kits, said Friday that it agreed to acquire U.S.-based diagnostic company Meridian Bioscience for 2 trillion won ($1.53 billion). This is the largest amount for an M&A deal in the domestic bio industry.

Baek Byung-yeul | 2022-07-08 16:48

Korea's bio industry at turning point after pandemic

Korea's bio industry at turning point after pandemic

SK Bioscience, Samsung Biologics and other Korean biotech companies are soaring to new heights as they succeed in locally developing vaccines, winning orders to manufacture the drugs and developing treatments for COVID-19, according industry officials, Thursday. “It is obvious that the pandemic raised the importance of securing proprietary vaccine development and manufacturin...

Baek Byung-yeul | 2022-07-03 10:25

SK Bioscience gets final approval for Korea's 1st COVID-19 vaccine

SK Bioscience gets final approval for Korea's 1st COVID-19 vaccine

SK Bioscience's SKYCovione, also known as GBP510, was approved for use, Wednesday, becoming Korea's first locally-developed COVID-19 vaccine to get the green light. The Ministry of Food and Drug Safety (MFDS) announced that it authorized the use of the recombinant protein-based vaccine.

Park Jae-hyuk | 2022-06-29 16:44

Korea approves use of 1st local COVID-19 vaccine from SK Bioscience

Korea approves use of 1st local COVID-19 vaccine from SK Bioscience

The government approved the use of SKYCovione, Wednesday, the country's first locally developed COVID-19 vaccine by SK Bioscience, taking a major step toward achieving vaccine sovereignty in the fight against the pandemic.

2022-06-29 15:02

SK Bioscience COVID-19 vaccine closer to final approval

SK Bioscience COVID-19 vaccine closer to final approval

SK Bioscience has moved one step closer toward rolling out Korea's first COVID-19 vaccine, as the government advisory panel of pharmaceutical experts determined that a license for the use of the vaccine can be granted, according to the Ministry of Food and Drug Safety (MFDS), Monday. “The COVID-19 vaccine developed by SK Bioscience is the first COVID-19 vaccine produced in Ko...

Baek Byung-yeul | 2022-06-27 15:32

[INTERVIEW] Embracing routine PCR test is key to preventing next virus: Seegene CEO

INTERVIEWEmbracing routine PCR test is key to preventing next virus: Seegene CEO

It's the middle of June and there is a chance that the country's new COVID-19 cases will surge again because of a rise in Omicron sub-variants currently being detected in the U.S. and Europe. The U.S. recently lifted its mandatory COVID testing for overseas travelers arriving by plane, which means that visitors no longer need to show negative test results or proof of recovery...

Kim Yoo-chul | 2022-06-16 12:34

SK Bioscience to test own COVID vaccine as booster

SK Bioscience to test own COVID vaccine as booster

SK Bioscience is set to conduct Phase 3 clinical trials of its COVID-19 vaccine in overseas countries to check its effectiveness as a booster shot. The biotech company also expects its vaccine could be approved by a health agency here, according to a company official, Monday.

Baek Byung-yeul | 2022-06-06 16:38

[INTERVIEW] Korea should strengthen ecosystem for clinical trials

INTERVIEWKorea should strengthen ecosystem for clinical trials

Over the last few years, the government has been supporting its strategy to help the country rise as a biotechnology hub in Asia given Korea's long-time competiveness in product manufacturing. The country's advantages in terms of having excellent infrastructure, workforce and IT platform have truly been beneficial amid COVID-19 as a number of biotechnology companies, includin...

Kim Yoo-chul | 2022-06-02 15:24

1 2 3 4 5 6 7 8 9 10

Top 10 Stories

1	Busan eyes Expo 2035 after losing to Riyadh

2	US, S. Korea cast doubt over NK's satellite photos

3	SPECIAL REPORTKorea should embrace cultural diversity in integrating immigrants

4	Saudi Expo win puts Korean firms in line for contracts

5	Journey into Tomorrow: Commemorating 140 years of Korean-German diplomatic relations

6	Busan citizens disappointed but ready for World Expo 2035 bid

7	Birthrate might fall below 0.7 in Q4

8	Chanel, Hermes, Nike rectify customer policies after FTC warning

9	Air Force awards 2 warrant officers as top air defense weapons controllers

10	Retailers, food firms rush to reduce workforce amid economic downturn

DARKROOM